Global Oncology Academy

Expert Insights on HER2 Scoring Criteria for Breast Cancer 

Expert Insights on HER2 Scoring Criteria for Breast Cancer
RestartResume

How do the 2018 ASCO/CAP guidelines redefine our approach to caring for patients with HER2-mutated breast cancer?

  • Overview

    How do the 2018 ASCO/CAP guidelines redefine our approach to caring for patients with HER2-mutated breast cancer? Find out as Dr. Jacob Sands speaks with Dr. Kathleen Fenn and Dr. Oudai Hassan about HER2 scoring criteria and how the data drives collaborative care between the medical oncology and pathology teams.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free